Serum choline plasmalogens-those with oleic acid in sn-2-are biomarkers for coronary artery disease

Clinica Chimica Acta

Volumn 437, Issue , 2014, Pages 147-154

  Nishimukai, Megumi ^a,d   Maeba, Ryouta ^b   Ikuta, Akiko ^a   Asakawa, Naoya ^c   Kamiya, Kiwamu ^c   Yamada, Shiro ^c   Yokota, Takashi ^c   Sakakibara, Mamoru ^c   Tsutsui, Hiroyuki ^c   Sakurai, Toshihiro ^a   Takahashi, Yuji ^a   Hui, Shu Ping ^a   Chiba, Hitoshi ^a   Okazaki, Tomoki ^b   Hara, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d IWATE UNIVERSITY   (Japan)

Author keywords

Choline plasmalogen; Coronary artery disease; Ether glycerophospholipid; LC MS MS; Plasmalogen; Significant coronary stenosis

Indexed keywords

1 O ALK 1' ENYL 2 ACYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 O ALK 1' ENYL 2 ACYL SN GLYCEROPHOSPHOLIPID; ADIPONECTIN; BIOLOGICAL MARKER; CHOLINE DERIVATIVE; ETHER CHOLINE GLYCEROPHOSPHOLIPID; ETHER GLYCEROPHOSPHOLIPID; GLYCEROPHOSPHOLIPID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLEIC ACID; LIPOPROTEIN; OLEIC ACID; PHOSPHOLIPID; PLASMALOGEN; RADIOACTIVE IODINE; UNCLASSIFIED DRUG; CHOLINE PLASMALOGENS;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; BLOOD;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OLEIC ACID; PLASMALOGENS; PROSPECTIVE STUDIES;

EID: 84910059075     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.024     Document Type: Article

References (43)

1. Gerszten R.E., Wang T.J. The search for new cardiovascular biomarkers. Nature 2008, 451:949-952.
2. Wilson P.W. CDC/AHA workshop on markers of inflammation and cardiovascular disease: Application to clinical and public health practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper. Circulation 2004, 110:e568-e571.
3. Wang T.J., Gona P., Larson M.G., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355:2631-2639.
4. Pepe M.S., Thompson M.L. Combining diagnostic test results to increase accuracy. Biostatistics 2000, 1:123-140.
5. Demopoulos C., Karantonis H., Antonopoulou S. Platelet activating factor - a molecular link between atherosclerosis theories. Eur J Lipid Sci Technol 2003, 105:705-716.
6. Zoeller R.A., Lake A.C., Nagan N., Gaposchkin D.P., Legner M.A., Lieberthal W. Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of vinyl ether. Biochem J 1999, 338:769-776.
7. Hahnel D., Thiery J., Brosche T., Engelmann B. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis. Arterioscler Thromb Vasc Biol 1999, 19:2431-2438.
8. Maeba R., Ueta N. Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers. J Lipid Res 2003, 44:164-171.
9. Wang W.Y., Albert C.J., Ford D.A. Alpha-chlorofatty acid accumulates in activated monocytes and causes apoptosis through reactive oxygen species production and endoplasmic reticulum stress. Arterioscler Thromb Vasc Biol 2014, 34:526-532.
10. Marsche G., Heller R., Fauler G., et al. 2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. Arterioscler Thromb Vasc Biol 2004, 24:2302-2306.
11. Nishimukai M., Maeba R., Yamazaki Y., et al. Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic state. J Lipid Res 2014, 55:956-965.
12. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
13. Hui S., Chiba H., Kurosawa T. Liquid chromatography-mass spectrometric determination of plasmalogens in human plasma. Anal Bioanal Chem 2011, 400:1923-1931.
14. Norris C., Fong B., MacGibbon A., McJarrow P. Analysis of phospholipids in rat brain using liquid chromatography-mass spectrometry. Lipids 2009, 44:1047-1054.
15. Schumaker V.N., Puppione D.L. Sequential flotation ultracentrifugation. Methods Enzymol 1986, 128:155-170.
16. Maeba R., Ueta N. Determination of choline and ethanolamine plasmalogens in human plasma by HPLC using radioactive triiodide (1-) ion (125I3-). Anal Biochem 2004, 331:169-176.
17. Maeba R., Yamazaki Y., Nezu T., Okazaki T. Improvement and validation of 125I-high-performance liquid chromatography method for determination of total human serum choline and ethanolamine plasmalogens. Ann Clin Biochem 2012, 49:86-93.
18. Schüep W., Rettenmaier R. Analysis of vitamin E homologs in plasma and tissue: high-performance liquid chromatography. Methods Enzymol 1994, 234:294-302.
19. Braverman N.E., Moser A.B. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 1822, 2012:1442-1452.
20. Ford D.A., Hale C.C. Plasmalogen and anionic phospholipid dependence of the cardiac sarcolemmal sodium-calcium exchanger. FEBS Lett 1996, 394:99-102.
21. Chen X., Gross R.W. Potassium flux through gramicidin ion channels is augmented in vesicles comprised of plasmenylcholine: correlations between gramicidin conformation and function in chemically distinct host bilayer matrices. Biochemistry 1995, 34:7356-7364.
22. Mitchell T.W., Buffenstein R., Hulbert A.J. Membrane phospholipid composition may contribute to exceptional longevity of the naked mole-rat (Heterocephalus glaber): a comparative study using shotgun lipidomics. Exp Gerontol 2007, 42:1053-1062.
23. 2+-independent PLA2 in hypoxic ventricular myocytes. Am J Physiol 1998, 274:C1727-C1737.
24. Beckett C.S., Kell P.J., Creer M.H., McHowat J. Phospholipase A2-catalyzed hydrolysis of plasmalogen phospholipids in thrombin-stimulated human platelets. Thromb Res 2007, 120:259-268.
25. Meyer M.C., McHowat J. Calcium-independent phospholipase A2-catalyzed plasmalogen hydrolysis in hypoxic human coronary artery endothelial cells. Am J Physiol Cell Physiol 2007, 292:C251-C258.
26. Messner M.C., Albert C.J., Hsub F.F., Ford D.A. Selective plasmenylcholine oxidation by hypochlorous acid: formation of lysophosphatidylcholine chlorohydrins. Chem Phys Lipids 2006, 144:34-44.
27. Albert C.J., Crowley J.R., Hsu F., Thukkani A.K., Ford D.A. Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal. J Biol Chem 2001, 276:23733-23741.
28. Thukkani A.K., Hsu F.F., Crowley J.R., Wysolmerski R.B., Albert C.J., Ford D.A. Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal. J Biol Chem 2002, 277:3842-3849.
29. Thukkani A.K., Albert C.J., Wildsmith K.R., et al. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein. J Biol Chem 2003, 278:36365-36372.
30. Thukkani A.K., McHowat J., Hsu F.F., Brennan M.L., Hazen S.L., Ford D.A. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 2003, 108:3128-3133.
31. Wallner S., Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid species. Chem Phys Lipids 2011, 164:573-589.
32. Van de Voorde J., Pauwels B., Boydens C., Decaluwé K. Adipocytokines in relation to cardiovascular disease. Metabolism 2013, 62:1513-1521.
33. Kishida K., Funahashi T., Shimomura I. Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab 2014, 28:119-130.
34. Kumada M., Kihara S., Sumitsuji S., et al. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
35. Patel J.V., Abraheem A., Dotsenko O., et al. Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J Intern Med 2008, 264:593-598.
36. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
37. von Eynatten M., Schneider J.G., Humpert P.M., et al. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. J Am Coll Cardiol 2006, 47:2124-2126.
38. Pietiläinen K.H., Sysi-Aho M., Rissanen A., et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoS One 2007, 2:e218.
39. Pietiläinen K.H., Róg T., Seppänen-Laakso T., et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 2011, 9:e1000623.
40. Nishimukai M., Yamashita M., Watanabe Y., et al. Lymphatic absorption of choline plasmalogen is much higher than that of ethanolamine plasmalogen in rats. Eur J Nutr 2011, 50:427-436.
41. Heilbronn L.K., Coster A.C., Campbell L.V., et al. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity 2013, 21:E649-E659.
42. Wang Z., Klipfell E., Bennett B.J., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
43. Tang W.H.W., Wang Z., Levison B.S., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013, 368:1575-1584.